Literature DB >> 23382392

Serotonin and dopamine in essential hypertension.

Charles T Stier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23382392      PMCID： PMC6267948          DOI： 10.1093/ajh/hps085

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN： 0895-7061            Impact factor:   2.689


× No keyword cloud information.
  6 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 2.  Dopamine receptor signaling defects in spontaneous hypertension.

Authors:  P A Jose; G M Eisner; J Drago; R M Carey; R A Felder
Journal:  Am J Hypertens       Date:  1996-04       Impact factor: 2.689

3.  Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice.

Authors:  Martin J Bek; Xiaoyan Wang; Laureano D Asico; John E Jones; Shaopeng Zheng; Xiaoxi Li; Gilbert M Eisner; David K Grandy; Robert M Carey; Patricio Soares-da-Silva; Pedro A Jose
Journal:  Hypertension       Date:  2005-12-27       Impact factor: 10.190

4.  Imbalance of renal production between 5-hydroxytryptamine and dopamine in patients with essential hypertension complicated by microalbuminuria.

Authors:  Masayo Hirose; Fumihiro Tomoda; Tsutomu Koike; Hidenori Yamazaki; Maiko Ohara; Hexing Liu; Satoshi Kagitani; Hiroshi Inoue
Journal:  Am J Hypertens       Date:  2012-12-28       Impact factor: 2.689

5.  Serotonin formation in nonblood-perfused rat kidneys.

Authors:  C T Stier; G McKendall; H D Itskovitz
Journal:  J Pharmacol Exp Ther       Date:  1984-01       Impact factor: 4.030

6.  Formation of serotonin by rat kidneys in vivo.

Authors:  C T Stier; H D Itskovitz
Journal:  Proc Soc Exp Biol Med       Date:  1985-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.